FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891646477> ?p ?o ?g. }

• W2891646477 endingPage "2877" @default.
• W2891646477 startingPage "2866" @default.
• W2891646477 abstract "Guillain-Barré syndrome is a heterogeneous disorder regarding the clinical presentation, electrophysiological subtype and outcome. Previous single country reports indicate that Guillain-Barré syndrome may differ among regions, but no systematic comparative studies have been conducted. Comparative studies are required to identify factors determining disease susceptibility, variation and prognosis, and to improve diagnostic criteria. The International Guillain-Barré Syndrome Outcome Study is a prospective, observational cohort study including all patients within the diagnostic spectrum, aiming to describe the heterogeneity of Guillain-Barré syndrome worldwide. The current study was based on the first 1000 inclusions with a follow-up of at least 1 year and confirmed the variation in clinical presentation, course and outcome between patients. The full clinical spectrum of Guillain-Barré syndrome was observed in patients from all countries participating in the International Guillain-Barré Syndrome Outcome Study, but the frequency of variants differed between regions. We compared three regions based on geography, income and previous reports of Guillain-Barré syndrome subtypes: ‘Europe/Americas’, ‘Asia’ (without Bangladesh), and ‘Bangladesh’. We excluded 75 (8%) patients because of alternative diagnoses, protocol violations, or missing data. The predominant clinical variant was sensorimotor in Europe/Americas (n = 387/562, 69%) and Asia (n = 27/63, 43%), and pure motor in Bangladesh (n = 74/107, 69%). Miller Fisher syndrome and Miller Fisher-Guillain-Barré overlap syndrome were more common in Asia (n = 14/63, 22%) than in the other two regions (Europe/Americas: n = 64/562, 11%; Bangladesh: n = 1/107, 1%) (P < 0.001). The predominant electrophysiological subtype was demyelinating in all regions (Europe/Americas: n = 312/573, 55%; Asia: n = 29/65, 45%; Bangladesh: n = 38/94, 40%). The axonal subtype occurred more often in Bangladesh (n = 34/94, 36%) than in Europe/Americas (n = 33/573, 6%) and other Asian countries (n = 4/65, 6%) (P < 0.001). In all regions, patients with the axonal subtype were younger, had fewer sensory deficits, and showed a trend towards poorer recovery compared to patients with the demyelinating subtype. The proportion of patients able to walk unaided after 1 year varied between Asia (n = 31/34, 91%), Europe/Americas (n = 334/404, 83%) and Bangladesh (n = 67/97, 69%) (P = 0.003). A similar variation was seen for mortality, being higher in Bangladesh (n = 19/114, 17%) than in Europe/Americas (n = 23/486, 5%) and Asia (n = 1/45, 2%) (P < 0.001). This study showed that factors related to geography have a major influence on clinical phenotype, disease severity, electrophysiological subtype, and outcome of Guillain-Barré syndrome." @default.
• W2891646477 created "2018-09-27" @default.
• W2891646477 creator A5000168044 @default.
• W2891646477 creator A5006476216 @default.
• W2891646477 creator A5009588500 @default.
• W2891646477 creator A5010308866 @default.
• W2891646477 creator A5017184747 @default.
• W2891646477 creator A5018546046 @default.
• W2891646477 creator A5020623639 @default.
• W2891646477 creator A5021996805 @default.
• W2891646477 creator A5023627853 @default.
• W2891646477 creator A5024169754 @default.
• W2891646477 creator A5031894298 @default.
• W2891646477 creator A5033269335 @default.
• W2891646477 creator A5035171547 @default.
• W2891646477 creator A5036040469 @default.
• W2891646477 creator A5037368893 @default.
• W2891646477 creator A5039280109 @default.
• W2891646477 creator A5042879776 @default.
• W2891646477 creator A5045462913 @default.
• W2891646477 creator A5045704441 @default.
• W2891646477 creator A5048129993 @default.
• W2891646477 creator A5048637965 @default.
• W2891646477 creator A5049139387 @default.
• W2891646477 creator A5050704861 @default.
• W2891646477 creator A5051132104 @default.
• W2891646477 creator A5054226440 @default.
• W2891646477 creator A5054368974 @default.
• W2891646477 creator A5055652589 @default.
• W2891646477 creator A5056379297 @default.
• W2891646477 creator A5057878321 @default.
• W2891646477 creator A5068619183 @default.
• W2891646477 creator A5068933418 @default.
• W2891646477 creator A5070182861 @default.
• W2891646477 creator A5070394837 @default.
• W2891646477 creator A5074759103 @default.
• W2891646477 creator A5075020182 @default.
• W2891646477 creator A5078228530 @default.
• W2891646477 creator A5082301295 @default.
• W2891646477 creator A5083528929 @default.
• W2891646477 creator A5085071867 @default.
• W2891646477 creator A5085889878 @default.
• W2891646477 creator A5086053655 @default.
• W2891646477 creator A5086443939 @default.
• W2891646477 creator A5087918389 @default.
• W2891646477 creator A5088344409 @default.
• W2891646477 date "2018-09-25" @default.
• W2891646477 modified "2023-10-18" @default.
• W2891646477 title "Regional variation of Guillain-Barré syndrome" @default.
• W2891646477 cites W1939037805 @default.
• W2891646477 cites W1971947774 @default.
• W2891646477 cites W1972339178 @default.
• W2891646477 cites W1974551350 @default.
• W2891646477 cites W1982576311 @default.
• W2891646477 cites W1985648558 @default.
• W2891646477 cites W1986245753 @default.
• W2891646477 cites W2006158276 @default.
• W2891646477 cites W2013392553 @default.
• W2891646477 cites W2015534015 @default.
• W2891646477 cites W2022258023 @default.
• W2891646477 cites W2023224657 @default.
• W2891646477 cites W2064309062 @default.
• W2891646477 cites W2065428699 @default.
• W2891646477 cites W2067903835 @default.
• W2891646477 cites W2080582088 @default.
• W2891646477 cites W2081532122 @default.
• W2891646477 cites W2081971318 @default.
• W2891646477 cites W2098397688 @default.
• W2891646477 cites W2125962985 @default.
• W2891646477 cites W2125996621 @default.
• W2891646477 cites W2127884861 @default.
• W2891646477 cites W2130371608 @default.
• W2891646477 cites W2147467901 @default.
• W2891646477 cites W2163550872 @default.
• W2891646477 cites W2170724226 @default.
• W2891646477 cites W2288486409 @default.
• W2891646477 cites W2335127767 @default.
• W2891646477 cites W2529168807 @default.
• W2891646477 cites W2531063489 @default.
• W2891646477 cites W2607286941 @default.
• W2891646477 cites W2609339598 @default.
• W2891646477 cites W2782725187 @default.
• W2891646477 cites W2783764530 @default.
• W2891646477 doi "https://doi.org/10.1093/brain/awy232" @default.
• W2891646477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30247567" @default.
• W2891646477 hasPublicationYear "2018" @default.
• W2891646477 type Work @default.
• W2891646477 sameAs 2891646477 @default.
• W2891646477 citedByCount "171" @default.
• W2891646477 countsByYear W28916464772018 @default.
• W2891646477 countsByYear W28916464772019 @default.
• W2891646477 countsByYear W28916464772020 @default.
• W2891646477 countsByYear W28916464772021 @default.
• W2891646477 countsByYear W28916464772022 @default.
• W2891646477 countsByYear W28916464772023 @default.
• W2891646477 crossrefType "journal-article" @default.
• W2891646477 hasAuthorship W2891646477A5000168044 @default.
• W2891646477 hasAuthorship W2891646477A5006476216 @default.

• next